Other languages Pulmonx Corporation

Equities

LUNG

US7458481014

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
6.94 ^USD	-1.98%		-4.28%	-45.57%

Jun. 04	Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target	MT
May. 01	Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pulmonx Corporation Provides Revenue Guidance for the Full Year 2024	May. 01
Pulmonx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01
Pulmonx kondigt behandeling aan van de eerste patiënt met het AeriSeal®-systeem in de CONVERT II-studie	Feb. 26
Pulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-Zulassungsstudie	Feb. 26
Pulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT II	Feb. 26
Pulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT II	Feb. 26
Pulmonx anuncia el tratamiento del primer paciente con el sistema AeriSeal® en el ensayo pivotal CONVERT II	Feb. 26
Pulmonx Corporation Announces Treatment of the First Patient with the Aeriseal System in Convert II Pivotal Trial	Feb. 26
Pulmonx Shares Fall After Wells Fargo Downgrade	Feb. 23
Pulmonx Corporation Provides Earnings Guidance for the Full Year 2024	Feb. 21
Pulmonx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21
Pulmonx Corporation Announces Chief Executive Officer Changes, Effective March 15, 2024	Feb. 21
Pulmonx Corporation Announces Executive Changes, Effective March 15, 2024	Feb. 21
Pulmonx Insider Sold Shares Worth $292,000, According to a Recent SEC Filing	Feb. 20
MÄRKTE USA/Wenig verändert vor Fed - Dow von Caterpillar und Amgen belastet	23-10-31
MÄRKTE USA/US-Börsen eröffnen im Minus - Renditen als Taktgeber	23-10-31
MÄRKTE USA/US-Börsen von Renditerückgang gestützt	23-10-31
Pulmonx Corporation Provides Earnings Guidance for 2023	23-10-30
Pulmonx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30
Pulmonx Finance Chief Derrick Sung Leaves, John McKune Named Interim CFO; Preliminary Q3 Revenue Issued	23-10-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pulmonx Corporation

Equities

LUNG

US7458481014

Other languages

Filters